Centro de Pesquisa em Álcool e Drogas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Serviço de Psicologia, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Braz J Psychiatry. 2022 Jan-Feb;44(1):103-110. doi: 10.1590/1516-4446-2020-1133.
Conduct a systematic review and meta-analysis to evaluate levels of anger among substance users compared to non-user controls and to analyze the possible association between anger and psychoactive substance use (PSU).
The procedures of this review followed the Meta-Analyzes of Observational Studies in Epidemiology (MOOSE) and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Four electronic databases (MEDLINE, EMBASE, BIREME, PsycINFO) were searched.
Twelve studies were included in the meta-analysis; 10 used the State-Trait Anger Expression Inventory (STAXI) anger trait subscale and two used the Buss-Perry-Aggression Questionnaire (BPAQ) anger subscale. The sample included 2,294 users of psychoactive substances and 2,143 non-users, all male. The mean difference in anger scale scores between users and non-users was 2.151 (95%CI 1.166-3.134, p ≤ 0.00, inconsistency index [I2] = 98.83) standard deviations. Age and abstinence duration did not moderate the difference in anger between substance users and non-users.
Users of psychoactive substances had elevated anger scores compared to non-users, which represents a high risk of relapse. It is suggested that PSU treatment programs include intensive anger management modules, focusing on factors such as dealing with daily stressors, family conflicts, frustrations, and problems.
系统评价和荟萃分析评估物质使用者与非使用者对照相比的愤怒水平,并分析愤怒与精神活性物质使用(PSU)之间的可能关联。
本综述的程序遵循观察性研究的荟萃分析中的生态学方法(MOOSE)和系统评价和荟萃分析的首选报告项目(PRISMA)指南。四个电子数据库(MEDLINE、EMBASE、BIREME、PsycINFO)进行了检索。
荟萃分析纳入了 12 项研究;其中 10 项使用状态特质愤怒表达量表(STAXI)愤怒特质子量表,2 项使用 Buss-Perry 攻击问卷(BPAQ)愤怒子量表。样本包括 2294 名精神活性物质使用者和 2143 名非使用者,均为男性。使用者和非使用者之间愤怒量表评分的平均差异为 2.151(95%CI 1.166-3.134,p≤0.00,不一致指数[I2]为 98.83)标准差。年龄和禁欲持续时间不能调节物质使用者和非使用者之间的愤怒差异。
与非使用者相比,精神活性物质使用者的愤怒评分升高,这代表着更高的复发风险。建议 PSU 治疗计划包括密集的愤怒管理模块,重点关注处理日常压力源、家庭冲突、挫折和问题等因素。